Skip to content
World News
-
Syntegon reports 19% sales growth in Q3 2025 driven by pharma innovation
The company’s Pharma business unit led the strong performance, delivering sales growth of 32%, including 20% organic growth.
-
AstraZeneca commits USD2B to expand Maryland manufacturing operations
The new facility will produce molecules for medical trials. These expansions will create 200 additional jobs in Frederick and 100 more in Gaithersburg.